32 completed, 6 unknown, 5 terminated, 5 withdrawn. 14 Phase 2, 14 Phase 3, 9 Not applicable, 7 Phase 1, 4 Phase 4.
Follow Gadolinium DTPA: new trials by email Literature Review of Gadolinium DTPA trials Research Report on Gadolinium DTPA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASIS for Enbrel in Plaque Psoriasis Gadolinium, Efficacy of Enbrel subcutaneously at Week 12, Efficacy of Enbrel subcutaneously at Week 24 - Plaque Psoriasis. | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Chronic Migraine Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12 - Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer. | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Upper Limb Spasticity Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12, - Upper Limb Spasticity Unilaterally in Adults With History of Stroke, Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors. | Phase 1 / Phase 2 | Unknown | li nguyen | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for GAMMAGARD in Primary Immunodeficiency Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard subcutaneously at Week 12 - Primary Immunodeficiency | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Cervical Dystonia Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12 - Cervical Dystonia Adults ,, Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus. | Phase 1 / Phase 2 | Unknown | li nguyen | 60 | 2016-01-01 | 2015-06-24 |
| Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults Iodohippurate, 24 hour ambulatory Blood Pressure, Peripheral Arterial Tonometry - Acute Kidney Injury, Chronic Kidney Disease | Withdrawn | University of Florida | 2015-12-01 | 2020-03-27 | ||
| Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection | Phase 4 | Completed | Paul Kim | 14 | 2015-11-01 | 2017-08-22 |
| Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury Manganese-enhanced MRI contrast reagent, Gadolinium-enhanced MRI contrast reagent - ISCHEMIC CARDIOMYOPATHY | Phase 1 / Phase 2 | Completed | Stanford University | 33 | 2015-04-01 | 2020-02-17 |
| Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis? Gadopentetate dimeglumine - Meniere Disease | Not applicable | Withdrawn | Emory University | 2015-02-01 | 2016-12-01 | |
| Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma Topotecan, Gadolinium DTPA, Cleveland Multiport Catheter - Malignant Glioma, WHO Grade III or IV Recurrent Glioma | Early Phase 1 | Completed | Michael Vogelbaum, MD, PhD | 3 | 2014-12-09 | 2017-03-31 |
| 3-Tesla MRI Response to TACE in HCC (Liver Cancer) 3 Tesla Magnetic Resonance Imaging, Magnevist® (Intravenous (IV) administration of MRI contrast agent) - Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 2 | 2014-02-01 | 2018-07-11 |
| Magnetic Resonance Imaging of Interscalene Plexus Block Interscalene Nerve Block, Ropivacaine 0.75%, 20ml, Gadopentetate-Dimeglumine 0.0125 mmol - Disorder of Shoulder | Phase 4 | Completed | Paracelsus Medical University | 30 | 2013-12-01 | 2014-07-10 |
| Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis 18F-FCH, Magnevist - Breast Cancer Diagnosis, Positron Emission Tomography | Phase 4 | Unknown | National Taiwan University Hospital | 80 | 2012-09-01 | 2016-02-04 |
| 3T MRI Biomarkers of Glioma Treatment Response 3-Tesla magnetic resonance imaging, CEST-MRI, DW-MRI - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Early Phase 1 | Terminated | Vanderbilt-Ingram Cancer Center | 7 | 2012-05-01 | 2017-04-17 |
| Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent Magnevist (gadopentetate dimeglumine) - Meniere's Disease | Not applicable | Completed | University of California, San Diego | 6 | 2012-01-01 | 2016-02-12 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadobutrol - Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma | Not applicable | Terminated | University of Southern California | 14 | 2011-12-14 | 2017-03-27 |
| Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions Dotarem (gadoterate meglumine), Magnevist (gadopentetate dimeglumine) - Diagnostic Self Evaluation, Central Nervous System Diseases | Phase 3 | Completed | Guerbet | 416 | 2010-09-01 | 2019-04-18 |
| Comprehensive Evaluation of Ischemic Heart Disease Using MRI Gadolinium, Adenosine - Heart Disease, Ischemic, Atherosclerosis, Coronary | Phase 2 / Phase 3 | Completed | Northwestern University | 40 | 2010-06-01 | 2014-09-26 |
| Contrast-enhanced MRI in Children 2 Months to <2 Years Gadopentetate dimeglumine (Magnevist, BAY86-6661) - Magnetic Resonance Imaging | Phase 3 | Completed | Bayer | 54 | 2010-01-01 | 2015-11-18 |
| Gadobutrol Magnevist-controlled Body Study Gadobutrol (Gadovist, BAY86-4875), Gadopentetate Dimeglumine (Magnevist, BAY86-4882) - Magnetic Resonance Imaging | Phase 3 | Completed | Bayer | 370 | 2010-01-01 | 2014-12-30 |
Showing 20 of 48. Sign in to see all of them.
Breast Neoplasms (5) · Brain Neoplasms (4) · Astrocytoma (3) · Ependymoma (3) · Glioblastoma (3) · Glioma (3) · Gliosarcoma (3) · Oligodendroglioma (3) · Peripheral Vascular Diseases (3) · Carcinoma, Hepatocellular (2) · Central Nervous System Diseases (2) · Choroid Plexus Neoplasms (2) · Medulloblastoma (2) · Meniere Disease (2) · Meningioma (2)
Bayer (14) · Bracco Diagnostics, Inc (4) · ASIS Corporation (3) · Stanford University (3) · American College of Radiology Imaging Network (2) · Northwestern University (2) · Vanderbilt-Ingram Cancer Center (2) · li nguyen (2) · Alliance for Clinical Trials in Oncology (1) · Children's Hospital of Philadelphia (1) · Emory University (1) · Guerbet (1) · Masonic Cancer Center, University of Minnesota (1) · Michael Vogelbaum, MD, PhD (1) · Milton S. Hershey Medical Center (1)
United States (29) · China (4) · Japan (4) · Germany (3) · Italy (3) · Argentina (2) · Austria (2) · South Korea (2) · Brazil (1) · Chile (1) · France (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Li Nguyen, MD (4) · Gianpaolo Pirovano, MD (2) · Thanh Phung, MD (2) · Thanh Phung,, MD (2) · Andrei Iagaru, MD (1) · Chad Quarles (1) · David L Gorden, MD (1) · Dr Andrew Quon (1) · Gerhard Fritsch, MD (1) · Gianpaolo Priovano, M.D. (1) · Hanh Nguyen, MD (1) · Hedvig Hricak, MD, PhD (1) · Hunt H. Batjer, MD (1) · James C Carr, MD (1)
PMID 21796368, PMID 22198468, PMID 22649152, PMID 16234512, PMID 16361632, PMID 17179104, PMID 17940305, PMID 19019414, PMID 19306364, PMID 21163915, PMID 22623692, PMID 23042922, PMID 23455520, PMID 25814661, PMID 26021444, PMID 26405167, PMID 26865133, PMID 26956325, PMID 29652233, PMID 31236756
2009 (2), P30CA014089 (1), P30CA068485 (1)